Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III
- PMID: 9354449
Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III
Abstract
Human papillomaviruses (HPVs), especially types 16 and 18, are strongly associated with the development of cervical intraepithelial neoplasia (CIN) and invasive carcinoma. The HPV E6 and E7 proteins are expressed constitutively in the majority of CIN lesions and carcinomas. Therefore, they are targets for the immune response against HPV and candidates for active immunotherapy. We have previously detected HPV-specific CTLs from the peripheral blood mononuclear cells from a cervical cancer patient following immunization with a recombinant vaccinia using in vitro restimulation with adenovirus recombinants expressing HPV16 or HPV18 E6/E7 fusion proteins. In this study, we used a similar protocol to determine the prevalence of CTL responses against HPV16 and HPV18 E6/E7 in the peripheral blood mononuclear cells from 10 CIN III and 10 normal subjects. HPV-specific CTL responses were detected in 6 of 10 CIN III subjects. These CTL lines recognized HPV16 E6/E7 proteins presented by at least three MHC class 1 HLA alleles and by HPV-transformed CaSki cells. No HPV-specific CTLs were detected in normal subjects. This study demonstrates the presence of naturally occurring HPV-specific memory CTLs in a majority of CIN III patients and provides an approach for further study of their role in modulating cervical malignancy.
Similar articles
-
Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.Cancer Res. 2000 Jan 15;60(2):365-71. Cancer Res. 2000. PMID: 10667589
-
Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.Clin Cancer Res. 2003 Nov 1;9(14):5205-13. Clin Cancer Res. 2003. PMID: 14614000 Clinical Trial.
-
Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes.Cancer Res. 1997 Jul 15;57(14):2943-50. Cancer Res. 1997. PMID: 9230206
-
Towards vaccines against human papillomavirus type-16 genital infections.Vaccine. 1993;11(6):603-11. doi: 10.1016/0264-410x(93)90302-e. Vaccine. 1993. PMID: 8391738 Review.
-
Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.J Infect Chemother. 2012 Dec;18(6):807-15. doi: 10.1007/s10156-012-0485-5. Epub 2012 Nov 3. J Infect Chemother. 2012. PMID: 23117294 Review.
Cited by
-
Development of therapeutic HPV vaccines.Lancet Oncol. 2009 Oct;10(10):975-80. doi: 10.1016/S1470-2045(09)70227-X. Lancet Oncol. 2009. PMID: 19796749 Free PMC article. Review.
-
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions.Cancer Immunol Immunother. 2012 Sep;61(9):1485-92. doi: 10.1007/s00262-012-1292-7. Epub 2012 Jun 9. Cancer Immunol Immunother. 2012. PMID: 22684521 Free PMC article. Clinical Trial.
-
Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection.Oncol Rev. 2012 Oct 5;6(2):e17. doi: 10.4081/oncol.2012.e17. eCollection 2012 Oct 2. Oncol Rev. 2012. PMID: 25992215 Free PMC article. Review.
-
Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses.Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11895-9. doi: 10.1073/pnas.1006500107. Epub 2010 Jun 14. Proc Natl Acad Sci U S A. 2010. PMID: 20547850 Free PMC article. Clinical Trial.
-
Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A*0201-restricted T-cell peptides in cervical cancer patients.J Virol. 2007 Mar;81(6):2869-79. doi: 10.1128/JVI.02256-06. Epub 2007 Jan 3. J Virol. 2007. PMID: 17202211 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials